SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

B of A Securities Reiterates Underperform on Teva Pharmaceutical Indus, Raises Price Target to $8

B of A Securities reiterates Teva Pharmaceutical Indus (NYSE:TEVA) with a Underperform and raises the price target from $7 to $8.

Benzinga · 05/08/2020 13:25

B of A Securities reiterates Teva Pharmaceutical Indus (NYSE:TEVA) with a Underperform and raises the price target from $7 to $8.